Webinar

Healthcare on the Hill: Navigating Political Risks and Opportunities

Bloomberg’s Healthcare Industry Specialist, Joanne Pigassou, will moderate a panel discussion exploring key issues shaping the healthcare landscape. She’ll be joined by Bloomberg Intelligence Healthcare analysts Duane Wright, Jonathan Palmer, Glen Losev, and Matt Henriksson. The conversation will primarily focus on potential impacts of Trump administration and Congressional policies on health insurers, healthcare facilities and service providers, medical devices, and life science tools.

Speakers

Joanne Pigassou

Global Healthcare Industry Specialist

Bloomberg

Joanne is a Global Healthcare Industry Specialist enabling Bloomberg's corporate healthcare clients to enhance their workflow productivity, supporting roles ranging from Investor Relations to Strategy/Business Development. Prior to joining Bloomberg, she spent 20 years as an equity buy-side analyst/PM investing in Healthcare at such shops as Alger, BlackRock and most recently Nuveen. She also worked at Lehman Brothers in sell-side equity research and spent a few years in investment banking. Joanne holds a Bachelor of Science from Boston College and earned her MBA at NYU Stern.

Duane Wright

Senior Health Policy Analyst

Bloomberg Intelligence

Duane Wright is a Senior Health Care Analyst for the health team at Bloomberg Intelligence. Prior to joining Bloomberg he was a Vice President in the Government Affairs department for the Advanced Medical Technology Association (AdvaMed) where he was team lead on diagnostics, coverage and reimbursement issues, and led industry efforts to repeal the medical device tax in 2019. Prior to AdvaMed he was a Vice President at Finsbury Glover Hering, a multi-client consultant firm, and America’s Health Insurance Plans. Prior to his private sector work he was lead health staff for Senator Tom Carper (D-DE), and a Legislative Assistant to former Congressman Jim Davis (D-FL). Wright holds a law degree from The George Washington University, and a bachelor’s degree from the University of North Carolina at Chapel Hill.

Jonathan Palmer

Senior Equity Research Analyst and Team Leader

Bloomberg Intelligence

Jonathan Palmer is a Senior Equity Research Analyst and Team Leader at Bloomberg Intelligence where he leads the group’s U.S. healthcare team. With more than two decades of experience in financial services and industry roles, he currently covers the Healthcare Technology & Distribution and Life Science & Diagnostics Tools sectors at Bloomberg. Previously, Jonathan was a sell-side analyst covering the Medical Supplies & Devices sector at CLSA. He also held a position as a long/short buy-side analyst at Thomas Weisel Partners and a hedge fund it spun out focusing on investments in non-therapeutic healthcare companies. Jonathan had joined Weisel’s sell-side research group on a Life Science & Diagnostics team before moving to the company’s asset management division. His career began at Pfizer where he was responsible for the financial planning and analysis function of the company’s European pharmaceutical division. He holds a MBA degree from the Tepper School of Business at Carnegie Mellon University, and a BS in Marketing from Pennsylvania State University.

Matt Henriksson

Senior MedTech Analyst

Bloomberg Intelligence

Matt Henriksson is a Senior Analyst for the healthcare team at Bloomberg Intelligence, covering Medical Technology stocks. Prior to joining Bloomberg, he was an Analyst at Citi Research and Senior Associate at BMO Capital Markets, where he also covered Medical Technology stocks. He holds an MBA from The Gabelli School of Business at Fordham University and a bachelor’s degree from Franklin & Marshall College.

Glen Losev

Senior Health Care Services Analyst

Bloomberg Intelligence

GLen Losev is a Senior Health Care Services Analyst for the health team at Bloomberg Intelligence. Prior to joining Bloomberg he was a part of the investment team at healthcare focused Montserrat Global Advisers where he focused on private and public investments and a healthcare analyst at a generalist focused Convector Capital where he focused on all healthcare verticals. Prior to that, he was a healthcare selvices analyst at Citigroup. Glen began his career at Oppenheimer & Co. as an associate on the pharma team but also worked on the medical devices team and launched healthcare services coverage.

Register

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.